Human Stage Holdings Corp. (321A) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Human Stage Holdings Corp. (321A:JPX), powered by AI.

Current Price
¥785
P/E Ratio
21.1
Market Cap
993M
Sector
Industrials
What is the Human Stage Holdings Corp. stock price forecast?

Human Stage Holdings Corp. is currently trading at ¥785. View real-time AI analysis on Alpha Lenz.

What is Human Stage Holdings Corp. insider trading activity?

View the latest insider trading data for Human Stage Holdings Corp. on Alpha Lenz.

What is Human Stage Holdings Corp.'s P/E ratio?

Human Stage Holdings Corp.'s P/E ratio is 21.1.

Human Stage Holdings Corp.

JPX · 321A
¥785Market closedJPX regular session 09:00–15:00 JST
Ask about Human Stage Holdings Corp.'s future dividend policy...
Alpha Chat Insight

Human Stage Holdings Corp. trades at a P/E of 21.1 (fair value) with modest ROE of 2.4%.

Ask for details

Company Overview

Human Stage Holdings Corp. is a diversified holding company involved in the management and operation of various subsidiaries across multiple industries. The primary function of this entity is to oversee and strategically guide its portfolio companies, optimizing value creation through efficient resource allocation and management expertise. Human Stage Holdings Corp. typically operates in sectors such as healthcare, technology, and consumer goods, thereby impacting a broad spectrum of markets and driving synergy between its diverse business units. As a holding company, it plays a crucial role in providing financial strength and stability to its subsidiaries, enabling them to focus on innovation and market expansion. Positioned at the intersection of strategic investment and operational management, Human Stage Holdings Corp. is significant in facilitating industry advancements through its dynamic and adaptable business model.

SectorIndustrials
IndustryConglomerates
0

Company Statistics

FY 2025

Profile

¥993,025,000Market Cap
¥4,054,647,000Revenue
0.00Shares Out
0Employees

Margins

16.97%Gross
-0.24%EBITDA
-1.17%Operating
1.61%Pre-Tax
1.16%Net

Valuation

21.06P/E
0.50P/B
0.24EV/Sales
-107.90EV/EBITDA
-7.06P/FCF

Growth (CAGR)

N/ARev 3Yr
N/ARev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

1.19%ROA
2.35%ROE
1.90%ROIC

Financial Health

¥1,331,850,000Cash & Cash Equivalents
¥559,782,000Net Debt
94.66%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Human Stage Holdings Corp. (ticker: 321A) is a company listed on JPX in the Industrials sector (Conglomerates). Market cap is $993M.

The current price is 785 with a P/E ratio of 21.06x and P/B of 0.5x.

ROE is 2.35% and operating margin is -1.17%. Annual revenue is $4.1B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Human Stage Holdings Corp. (321A) Stock Forecast 2026 ¥785 — Price, Financials & Analyst Targets | Alpha Lenz